ANTHONY ROSARIO: Open Payments
NPI 1578019014 · CAMBRIDGE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,334 in 53 payments from 10 companies in 2025. Trend: 2023 $96 · 2024 $38 · 2025 $2,334
Food & beverage: $1,667Travel & lodging: $667
| Company | Payments | Amount |
|---|---|---|
| Enterra Medical, Inc. | 5 | $1,284 |
| ABBVIE INC. | 26 | $582 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $161 |
| Phathom Pharmaceuticals, Inc. | 4 | $80 |
| Madrigal Pharmaceuticals | 2 | $72 |
| QOL Medical, LLC | 2 | $41 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
| Digestive Care, Inc. | 1 | $33 |
| Ardelyx, Inc. | 2 | $31 |
| Alnylam Pharmaceuticals Inc. | 1 | $17 |
Products named: LINZESS, XIFAXAN, CREON, RINVOQ, VOQUEZNA, REZDIFFRA, Sucraid, VOWST.
Industry payments across MD — which companies pay providers there.
